ImmuCell (ICCC) to Release Quarterly Earnings on Thursday

ImmuCell (NASDAQ:ICCC) will be issuing its quarterly earnings data after the market closes on Thursday, May 9th. Investors that are interested in registering for the company’s conference call can do so using this link.

ImmuCell (NASDAQ:ICCC) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported ($0.15) earnings per share for the quarter. ImmuCell had a negative net margin of 33.05% and a negative return on equity of 21.79%. The business had revenue of $5.10 million during the quarter.

ImmuCell Stock Up 0.4 %

Shares of NASDAQ:ICCC opened at $5.11 on Wednesday. ImmuCell has a 12 month low of $4.26 and a 12 month high of $6.05. The firm has a market cap of $39.96 million, a P/E ratio of -6.81 and a beta of 0.60. The company has a quick ratio of 0.87, a current ratio of 2.73 and a debt-to-equity ratio of 0.42. The company’s 50-day moving average price is $5.15 and its two-hundred day moving average price is $5.01.

About ImmuCell

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.